TAG / FDA

The Citizens Commission on Human Rights says FDA approval of antidepressants ignores decades of documented, permanent harms and calls for a full independent investigation into PSSD.

Federal courts, costly class action litigation and safety alerts haven’t stopped Botanic Tonics from selling $250 million a year of a product that leaves addicts warning, “I thought I was going to die.”

A surge in overdoses tied to the synthetic compound 7-OH has triggered emergency action in Los Angeles County. Regulators warn that products sold as natural remedies mask opioid-like disasters.

Factors like sex, race or foster care status didn’t explain the fivefold jump in psychotropic stacking. The results expose a system primed to drug children rather than help them.

From smoke shops to health food stores, highly addictive kratom formulas exploit legal loopholes, putting communities across the US in danger.

A landmark reform shuts down deceptive drug ads that fueled overprescribing, misinformation and billions in profits for Big Pharma.

From gummies to wrongful death lawsuits, the billion-dollar rise of “gas station heroin” is colliding with bans, bereaved families and the FDA’s harshest crackdown yet.

A 10‑member FDA panel met amid mounting evidence that antidepressants may impair fetal brain development.

Psychiatrists push for electroshock on children—even as global bodies condemn it, courts rebuke it and victims recount the brain damage it leaves behind.

Evidence suggests drugmakers manipulated trials and government failed to respond while patients live with permanent loss of sexual function.